Bosh sahifaPLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
2,85 $
Seans yopilganidan keyin:(0,00%)0,00
2,85 $
Yopilgan:25-apr, 16:01:33 (GMT-4) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
2,94 $
Kunlik diapazon
2,84 $ - 3,04 $
Yillik diapazon
0,82 $ - 3,04 $
Bozor kapitalizatsiyasi
222,39 mln USD
Oʻrtacha hajm
750,02 ming
Narx/foyda
78,79
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 18,22 mln | 73,74% |
Joriy xarajat | 7,12 mln | -1,68% |
Sof foyda | 6,49 mln | 207,45% |
Sof foyda marjasi | 35,65 | 161,85% |
Har bir ulushga tushum | — | — |
EBITDA | 7,54 mln | 242,27% |
Amaldagi soliq stavkasi | 11,24% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 34,83 mln | -21,84% |
Jami aktivlari | 73,42 mln | -13,05% |
Jami passivlari | 30,21 mln | -40,62% |
Umumiy kapital | 43,21 mln | — |
Tarqatilgan aksiyalar | 78,03 mln | — |
Narxi/balansdagi bahosi | 5,16 | — |
Aktivlardan daromad | 26,70% | — |
Kapitaldan daromad | 41,50% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 6,49 mln | 207,45% |
Operatsiyalardan naqd pul | 3,99 mln | 11,02% |
Sarmoyadan naqd pul | -15,32 mln | -4 379,53% |
Moliyadan naqd pul | 3,63 mln | — |
Naqd pulning sof oʻzgarishi | -7,65 mln | -337,10% |
Boʻsh pul | 1,67 mln | -71,01% |
Haqida
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Tashkil etilgan
1993
Bosh ofis
Sayt
Xodimlar soni
213
